Sarah Drukarch
Partner
Attorney at Law
Feldeggstrasse 4
8008 Zurich
Suisse
T +41 44 217 93 23
sarah.drukarch@pestalozzilaw.com
Sarah Drukarch is a partner and member of Pestalozzi’s IP & TMT, Life Sciences, as well as Corporate/M&A practice groups in Zurich. She specializes in intellectual property, with a particular focus on life sciences, and also frequently advises clients on matters of unfair competition, data protection, food and healthcare as well as IT and media law. Sarah's expertise has been recognized by her continued inclusion as Rising Star for Switzerland by IP Stars since 2020.
Carrière
- Partner at Pestalozzi
- Part time secondment at a global medical device manufacturer advising the local business units for the end customer market
- Senior Associate at Pestalozzi
- Part time secondment at a global medical device manufacturer focusing on contractual & regulatory requirements for clinical trials
- Associate at Pestalozzi
- Admission to Swiss bar
- Junior Associate at Pestalozzi
- University of Lucerne: Master of Law
- Exchange student Temple University Beasley School of Law, Philadelphia
- University of Lucerne: Bachelor of Law
Langues
Allemand, Anglais, Hébreu, Italien, Hollandais, Français
Compétences & Industries
Corporate / M&AEnvironnementaux, Sociaux et de Gouvernance (ESG)
IP & TMT
Life Sciences (sciences de la vie)
Adhésion
- Swiss Bar Association (SAV)
- Zurich Bar Association (ZAV)
- International Association for the Protection of Intellectual Property (AIPPI)
- International Association of Privacy Professionals (IAPP)
- International Bar Association (IBA), officer in the IP and Entertainment Law Committee
- Licensing Executives Society Switzerland (LES)
- Pharmaceutical Trade Marks Group (PTMG)
- Swiss Association for Intellectual Property Law (INGRES)
Deals and Cases
Pestalozzi advised Adragos Pharma in the Acquisition of Baccinex
Pestalozzi advised Adragos Pharma in the Acquisition of Baccinex
Pestalozzi advises Swiss Life Asset Managers in connection with the acquisition of Condecta
Pestalozzi advises Swiss Life Asset Managers in connection with the acquisition of Condecta
Pestalozzi advised Corza Medical on its acquisition of Tachosil manufacture operations from Takeda
Pestalozzi advised Corza Medical on its acquisition of Tachosil manufacture operations from Takeda